Ten stocks stood firmer on Monday, bucking a mixed performance in the broader market, as investors took heart from a flurry of company-specific developments and an improving macroeconomic front.
On Wall Street, only the S&P 500 and the Nasdaq finished in the green, up by 0.12 percent and 0.20 percent, respectively. In contrast, the Dow Jones dropped by 0.13 percent.
Indices aside, this article spotlights the names of the 10 top performers and breaks down the reasons behind their gains.
To come up with the list, we focused on the stocks with a $2 billion market capitalization and 5 million shares in trading volume.
Photo by George Morina on Pexels
10. TeraWulf Inc. (NASDAQ:WULF)
TeraWulf grew its share price by 7.15 percent on Monday to close at $21.43, after an analyst raised its price target by double digits and posted a bullish outlook for the company.
In a market note, Morgan Stanley upgraded its price target for TeraWulf Inc. (NASDAQ:WULF) by 12 percent to $41.50 from $37 previously, while maintaining an “overweight” recommendation, citing its valuation as a bitcoin-to-data-center company as “increasingly attractive.”
Morgan Stanley said that TeraWulf Inc. is slated for growth upside amid recently clinched deals, including the development and leasing of facilities to AI players, such as Google, supported by ongoing expansion plans to boost its portfolio.
It can be learned that the listed firm earlier this year acquired two land parcels in Kentucky and Maryland for the development of some 1,480 MW of new digital and power capacity.
Meanwhile, Morgan Stanley said that TeraWulf Inc.’s preliminary results showed significant progress in its conversion plans, with over half of its revenues coming from high-performance computing (HPC) hosting, and more capacity expected to come online by year-end.
For the first quarter of the year, TeraWulf is targeting to report $30 million to $35 million in revenues, or an implied decline of 12.8 percent or growth of 1.7 percent from the $34.4 million registered in the same period last year.
Official results are expected to be released in the first week of May 2026, based on its historical reporting dates.
9. Lionsgate Studios Corp. (NYSE:LION)
Lionsgate rallied for a third straight day on Monday, climbing 7.09 percent to close at $12.24, after its new film hit box-office records, while investors digested an investment firm’s 25-percent price target upgrade for its stock.
According to a report by NBC, Lionsgate Studios Corp.’s (NYSE:LION) new film, Michael—which depicts the life of Michael Jackson—generated $217 million in global sales in its first weekend of release. Of the total, $97 million was sold locally, while the remaining $120.4 million was generated internationally.
The figures exceeded expectations of only $50 million to $70 million prior to the release.
Michael was also Lionsgate Studios Corp.’s top bow since the pandemic, exceeding The Hunger Games: Mockingjay – Part 2, which raked in $102.7 million.
Meanwhile, investors took heart from Benchmark’s price target upgrade for Lionsgate Studios Corp., to $15 from $12 previously, while maintaining a “buy” recommendation. The figure marked a 22.5 percent upside potential from its latest closing price.
In other news, Lionsgate Studios Corp. earlier this month updated its employment contract with its CEO, Jon Feltheimer, under which, he was given an option to buy 4.5 million shares at $11.07 apiece, and a chance to receive 666,667 restricted stock units upon the achievement of certain conditions, including hitting certain price targets within five years, and if he stays in the company for five years.
The agreement forms part of the company’s broader efforts to compensate Feltheimer and support his strategy for driving Lionsgate’s growth.
8. Snap Inc. (NYSE:SNAP)
Snap rallied by 7.26 percent on Monday to close at $6.06 apiece, after an investment firm doubled its price target and turned bullish for its stock ahead of the first quarter earnings outcome.
In a market note, Rothschild upgraded Snap Inc. (NYSE:SNAP) to “buy” from “neutral” previously, while doubling its price target to $10 from $5 prior. The price marked a 65 percent upside potential from its latest closing price.
The coverage reflected its optimism for the technology firm’s diversified revenues and cost management efforts, adding that it expects the latter to have already reached breakeven in 2025 and be on the path to profitability in fiscal year 2026.
By 2028, Rothschild projects Snap Inc. to grow at a compounded annual growth rate (CAGR) of 11 percent, driven by a 7 percent CAGR in advertising and a sharp increase in subscription revenues, to $1.755 billion in 2028 from $745 million in 2025.
Subscription revenues are projected to grow to 22 percent from 13 percent of total revenues, while gross margins are pegged at 63 percent in 2028 versus 55 percent in 2025.
In other developments, Snap Inc. is set to announce the results of its earnings performance for the first quarter after market close on Wednesday, May 6. A conference call will be held to elaborate on the results.
For the period, it is targeting to grow its revenues by 12 percent to $1.529 billion from the $1.363 billion in the same period last year. Adjusted EBITDA is expected at $233 million, or a 116 percent jump from the $108 million year-on-year.
7. USA Rare Earth Inc. (NASDAQ:USAR)
USA Rare Earth surged by 7.50 percent on Monday to finish at $23.51 apiece, as investors loaded portfolios ahead of the results of its earnings performance in the first quarter of the year.
Based on its earnings report for the same period last year, USA Rare Earth Inc. (NASDAQ:USAR) is expected to release its financial and operating highlights between May 11 and 15, 2026.
In recent news, USA Rare Earth Inc. announced the acquisition of a rare earth miner for $2.8 billion.
In an updated report, USA Rare Earth Inc. said that it inked a definitive agreement with Serra Verde Group for the acquisition of its entire stake for a combination of cash and stock transaction.
Serra Verde, which owns the Pela Ema rare earth mine and processing plant in Goiás, Brazil, will be acquired for $300 million in cash and more than 126.8 million USAR shares.
The transaction is expected to close in the third quarter of the year, subject to customary closing conditions and regulatory approvals.
“The acquisition of Serra Verde represents a transformational step in delivering on our ambition to build a global champion and the partner of choice in rare earth elements, oxides, metals and magnets,” USA Rare Earth Inc. CEO Barbara Humpton said, noting that Serra Verde is the only producer outside Asia capable of supplying all four magnetic rare earths at scale, including Dysprosium, Yttrium, and Terbium.
“By combining Serra Verde’s world-class operations and team with our processing, separation, metallization, and magnet-making capabilities, we are advancing our goal of creating a fully integrated platform that will serve as a cornerstone of global rare earth supply security for decades to come,” she added.
6. Fastly Inc. (NASDAQ:FSLY)
Fastly snapped a three-day losing streak on Monday, surging 8.59 percent to close at $25.80 apiece, as investors repositioned portfolios ahead of the results of its first-quarter earnings performance.
In a notice to investors, Fastly Inc. (NASDAQ:FSLY) said that it would release its financial and operating highlights after market close on Wednesday, May 6. A conference call will be held to elaborate on the results.
For the period, the company is targeting to grow its revenues by 16 to 20.4 percent to a range of $168 million to $174 million, versus the $144.5 million in the same period last year.
It also expects to swing to a non-GAAP net income per share of $0.07 to $0.10 from a non-GAAP net loss per share of $0.05 posted in the same comparable period.
Non-GAAP operating income is pegged at $14 million to $18 million, or an implied reversal of the $5.8 million non-GAAP operating loss year-on-year.
In other news, Fastly Inc. earlier this month teamed up with Spain-based professional football association, Laliga, in combating piracy and illegal streaming of its live sports.
Under the agreement, Fastly Inc. and Laliga will collaborate on a joint anti-piracy innovation project leveraging AI for a targeted, intelligent detection system that is able to identify illegal streams in real time.
Fastly and Laliga said that they are actively collaborating with other technology companies, publishers, and regulators to develop software solutions and best practices that quickly detect and disable unauthorized streaming while leaving all other traffic untouched.
5. Cleveland-Cliffs Inc. (NYSE:CLF)
Shares of Cleveland-Cliffs jumped by 8.71 percent on Monday to finish at $10.61 apiece, as investors loaded portfolios in high-growth industries, with optimism supported by the US and Iran’s plan to end the war.
Cleveland-Cliffs Inc. (NYSE:CLF)—a US-based steel producer—has been attracting investor attention recently, supported by its efforts to diversify into the rare earths sector.
Last year, Cleveland-Cliffs Inc. announced that it officially kicked off efforts to expand beyond steelmaking and into rare earth mining, with the potential of two mining sites in Michigan and Minnesota being explored at present.
“If successful, it would align Cleveland-Cliffs with the broader national strategy for critical material independence, similar to what we achieved in steel. American manufacturing shouldn’t rely on China or any foreign nation for essential minerals, and Cliffs intends to be part of the solution,” Goncalves said.
Rare earth mining is one of the highly-prioritized industries identified by President Donald Trump, in line with his goals to reduce the United States’ reliance on China for rare earths.
In other news, Cleveland-Cliffs Inc. said last week that it narrowed its net loss attributable to shareholders by 52.4 percent to $237 million from $498 million in the same period last year. Revenues increased by 6 percent to $4.9 billion from $4.6 billion year-on-year.
4. Uranium Energy Corp. (NYSEAmerican:UEC)
Uranium Energy grew its share prices by 9.68 percent on Monday to finish at $15.41 apiece, as investor optimism was fueled by the improving macroeconomic conditions after the US and Iran hinted at ending the war.
In other news, Uranium Energy Corp. (NYSEAmerican:UEC) recently secured the approval of the Texas Commission on Environmental Quality (TCEQ) for its Buke Hollow project, paving the way for the commencement of operations.
Uranium Energy Corp. (NYSEAmerican:UEC) said that the development will be the first in-situ recovery uranium to be operating in over a decade.
Production will be processed at the Hobson Central Processing Plant, which is licensed to produce up to 4 million pounds of uranium per year.
“The startup of Burke Hollow is a significant achievement for UEC, advancing the project from a grassroots discovery in 2012 to production in 2026. With two ISR operations now producing, and our Ludeman ISR project planned for startup in 2027, we are building a scalable, multi-faceted platform supported by the largest uranium resource base in the United States,” said Uranium Energy Corp. (NYSEAmerican:UEC) President and CEO Amir Adnani.
“Our 100 percent unhedged, staged production growth strategy positions UEC to meet strengthening market fundamentals and growing U.S. policy support for the domestic nuclear fuel supply chain,” he added.
3. Oruka Therapeutics Inc. (NASDAQ:ORKA)
Oruka Therapeutics soared to a new record high on Monday, as investors positioned portfolios following positive results from the clinical study of its psoriasis treatment candidate, ORKA-001.
In an updated report, Oruka Therapeutics Inc. (NASDAQ:ORKA) said that 40 of the 63 enrolled patients treated with ORKA-001 achieved the primary endpoint of PASI 100 at Week 16, representing a complete skin clearance.
Based on a cross-trial comparison, ORKA-001 demonstrated numerically higher rates of skin clearance than all other IL-23p19 inhibitors.
Additionally, ORKA-001 recorded a safety profile and recorded no serious treatment-emergent adverse effects.
Following the news, shares of Oruka Therapeutics Inc. climbed to their highest price of $91 in intra-day trading on Monday before paring gains to finish the session just up by 10.66 percent at $76.39 apiece.
“These data reached the top end of what we could have expected from ORKA-001 across efficacy, tolerability, and potential for long-lasting response,” Oruka Therapeutics Inc. Chief Medical Officer Joana Goncalves said.
“We’re thrilled with the profile that is emerging for this program and are excited to see how the data matures with longer-term follow-up,” she added.
Longer-term data from the study, covering 28 weeks of treatment, is set to be provided in the second half of the year.
2. Organon & Co. (NYSE:OGN)
Organon soared to a new 52-week high on Monday, as investors gobbled up shares after the company officially confirmed its planned $11.75-billion merger with Sun Pharmaceuticals.
In intra-day trading, the stock climbed to its highest price of $13.24 before trimming gains to finish the session just up by 16.87 percent at $13.16 apiece.
In a joint statement, Organon & Co. said that Sun Pharma is set to acquire all its outstanding shares at $14 apiece, in an all-cash transaction, in line with the latter’s strategy of growing its innovative medicines business.
The transaction officially secured the green light of both firms’ board of directors and is now up for approval by the shareholders.
“Following a comprehensive review of strategic alternatives, our board determined that this all‑cash transaction offers compelling and immediate value to Organon stockholders. We believe Sun Pharma is well-positioned to support Organon’s businesses, employees, and patients globally, and to further advance our commitment to delivering impactful medicines and solutions,” said Organon & Co. Executive Chairman Carrie Cox.
The transaction is expected to close in early 2027, subject to other customary closing conditions.
Organon & Co. is a global leader in women’s health. It was formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021.
1. X-Energy Inc. (NASDAQ:XE)
X-Energy soared higher in its second day as a publicly listed company, climbing 23.22 percent to close at $35.98 apiece on Monday, as investors resumed buying positions amid the rosy prospects for the nuclear sector.
Last Friday, X-Energy Inc. (NASDAQ:XE) debuted on the stock market, successfully raising $1.017 billion in fresh funds from the sale of 44.2 million Class A shares. As of Monday’s trading, the company is valued at $14 billion.
In connection with the offering, X-Energy Inc. granted its underwriters a 30-day option to purchase up to an additional 6.6 million shares.
If fully subscribed, this would increase its offer by another $152.68 million, for a total of $1.169 billion.
X-Energy Inc. is a leading developer of advanced small modular nuclear reactors and fuel technology for clean energy generation.
In 2024, it earned the backing of e-commerce giant Amazon by being both an investor and a client, as the latter ramps up its plans to secure energy services from small modular reactors.
It also earned the backing of Cathie Wood’s Ark Invest, following the latter’s $120 million investment in the company.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Hedge Fund Resource Center